
  
    
      
        Background_NNP
        The_DT analysis_NN of_IN gene_NN function_NN during_IN mammalian_JJ embryonic_JJ
        development_NN relies_VBZ heavily_RB on_IN the_DT use_NN of_IN transgenic_JJ mice_NNS ._.
        However_RB ,_, expression_NN of_IN alleles_NNS that_WDT result_NN in_IN embryonic_JJ
        lethality_NN cannot_NN be_VB studied_VBN using_VBG regular_JJ transgenic_JJ
        procedures_NNS because_IN lines_NNS of_IN founder_NN mice_NNS cannot_NN be_VB
        established_VBN ._. Analysis_NNP of_IN such_JJ alleles_NNS in_IN mammals_NNS has_VBZ
        historically_RB relied_VBN upon_IN transient_JJ transgenic_JJ procedures_NNS [_NN
        1_CD ]_NN ._. In_IN this_DT approach_NN ,_, fertilized_VBN eggs_NNS are_VBP injected_VBN with_IN a_DT
        transgene_NN construct_VB and_CC allowed_VBN to_TO develop_VB to_TO a_DT
        pre-determined_JJ embryonic_JJ stage_NN 
        in_IN utero_NN before_IN being_VBG collected_VBN for_IN
        phenotypic_JJ analysis_NN ._. Using_VBG this_DT method_NN a_DT variable_JJ number_NN of_IN
        transgenes_NNS integrate_VB into_IN random_JJ genomic_JJ loci_NN ._.
        Unfortunately_RB ,_, the_DT local_JJ chromosomal_NN environment_NN can_MD affect_VB
        expression_NN of_IN the_DT integrated_VBN transgene_NN and_CC this_DT can_MD result_VB
        in_IN unpredictable_JJ transgene_NN expression_NN ._. Moreover_RB ,_, because_IN no_DT
        founder_NN line_NN is_VBZ established_VBN it_PRP is_VBZ not_RB possible_JJ to_TO repeat_VB an_DT
        analysis_NN with_IN a_DT specific_JJ transgenic_JJ mouse_NN embryo_NN ._.
        The_DT problem_NN of_IN random_JJ transgene_NN integration_NN can_MD be_VB
        overcome_VBN by_IN targeting_VBG transgenes_NNS to_TO a_DT specific_JJ genomic_JJ
        locus_JJ by_IN homologous_RB recombination_NN in_IN ES_NNP cells_NNS [_NN 2_CD 3_CD 4_CD ]_NN ._. A_DT
        method_NN that_WDT allows_VBZ the_DT introduction_NN of_IN single_JJ copy_NN
        transgenes_NNS into_IN the_DT X-_NNP linked_VBD 
        hprt_NN locus_JJ has_VBZ been_VBN described_VBN
        previously_RB by_IN Bronson_NNP 
        et_CC al_NN [_NN 2_CD ]_NN ._. In_IN this_DT approach_NN
        single-copy_JJ transgenes_NNS are_VBP introduced_VBN 5_CD '_POS of_IN the_DT 
        hprt_NN locus_JJ by_IN homologous_RB
        recombination_NN in_IN ES_NNP cells_NNS ._. This_DT is_VBZ an_DT extremely_RB efficient_JJ
        procedure_NN because_IN targeted_VBN clones_NNS have_VBP reconstituted_JJ the_DT 
        hprt_NN gene_NN and_CC are_VBP selected_VBN on_IN the_DT
        basis_NN of_IN growth_NN in_IN HAT_NNP medium_NN ._. Following_VBG this_DT method_NN ,_,
        upward_RB of_IN 90_CD %_NN of_IN HAT_NNP resistant_JJ ES_NNP cell_NN clones_NNS contain_VBP
        correctly_RB targeted_VBN transgenes_NNS [_NN 2_CD ]_NN ._. The_DT 
        hprt_NN locus_JJ is_VBZ a_DT particularly_RB suitable_JJ
        site_NN for_IN the_DT integration_NN of_IN transgenes_NNS because_IN it_PRP exists_VBZ as_IN
        an_DT X-_NNP linked_VBD gene_NN present_JJ as_IN a_DT single_JJ copy_NN in_IN male_JJ ES_NNP cells_NNS ._.
        Moreover_RB ,_, the_DT 
        hprt_NN gene_NN is_VBZ ubiquitously_RB expressed_VBN
        and_CC so_RB provides_VBZ a_DT favorable_JJ chromatin_NN environment_NN for_IN
        transgene_NN expression_NN ._. Indeed_RB ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN
        the_DT level_NN of_IN expression_NN of_IN transgenes_NNS inserted_VBN into_IN the_DT 
        hprt_NN locus_JJ is_VBZ directed_VBN solely_RB by_IN
        exogenous_JJ transcriptional_NN regulatory_JJ elements_NNS [_NN 2_CD ]_NN ._.
        Furthermore_RB ,_, mice_NNS derived_VBN from_IN independent_JJ ES_NNP cells_NNS clones_NNS
        containing_VBG a_DT transgene_NN expressed_VBD from_IN the_DT same_JJ promoter_NN all_DT
        exhibit_NN comparable_JJ levels_NNS of_IN expression_NN [_NN 2_CD 4_CD 5_CD 6_CD ]_NN ._.
        Although_IN the_DT targeting_VBG of_IN constructs_NNS to_TO the_DT 
        hprt_NN locus_JJ facilitates_NNS consistent_JJ
        expression_NN of_IN transgenes_NNS it_PRP does_VBZ not_RB overcome_VB the_DT need_NN to_TO
        generate_VB founder_NN lines_NNS of_IN transgenic_JJ mice_NNS ._. However_RB ,_,
        pioneering_JJ work_NN by_IN Nagy_NNP 
        et_CC al_NN has_VBZ shown_VBN that_IN embryos_NNS and_CC mice_NNS
        can_MD be_VB derived_VBN directly_RB from_IN R_NN 1_CD ES_NNP cells_NNS by_IN aggregating_VBG
        them_PRP with_IN tetraploid_NN embryos_NNS [_NN 7_CD 8_CD ]_NN ._. This_DT suggests_VBZ that_WDT
        controlled_VBD expression_NN of_IN transgenes_NNS encoding_VBG possible_JJ
        gain-of-function_JJ and_CC developmental-lethal_JJ alleles_NNS could_MD be_VB
        achieved_VBN by_IN generating_VBG embryos_NNS and_CC /_NN or_CC mice_NNS from_IN ES_NNP cells_NNS
        containing_VBG transgenes_NNS inserted_VBN into_IN the_DT 
        hprt_NN locus_JJ ._. Unfortunately_RB ,_, the_DT
        generation_NN of_IN mice_NNS and_CC embryos_NNS by_IN tetraploid_NN aggregation_NN
        from_IN available_JJ Hprt_NNP negative_JJ ES_NNP cell_NN lines_NNS has_VBZ proven_VBN to_TO be_VB
        inefficient_JJ and_CC unreliable_JJ (_( S_NNP ._. A_DT ._. D_NNP ._. unpublished_JJ )_) ._. In_IN this_DT
        report_NN ,_, we_PRP describe_VBP the_DT generation_NN of_IN a_DT new_JJ Hprt_NNP negative_JJ
        ES_NNP cell_NN line_NN that_WDT is_VBZ compatible_JJ with_IN the_DT tetraploid_NN
        aggregation_NN procedure_NN ._. Moreover_RB ,_, we_PRP demonstrate_VBP that_IN it_PRP
        facilitates_NNS efficient_JJ targeting_VBG of_IN transgenes_NNS to_TO the_DT 
        hprt_NN locus_JJ as_IN well_RB as_IN the_DT subsequent_JJ
        generation_NN of_IN clonal_NN transgenic_JJ mouse_NN embryos_NNS that_WDT express_VBP
        the_DT transgene_NN in_IN a_DT promoter-dependent_JJ manner_NN ._.
      
      
        Results_NNS
        Nagy_NNP 
        et_CC al_NN demonstrated_VBN that_IN embryos_NNS and_CC
        mice_NNS could_MD be_VB derived_VBN solely_RB from_IN R_NN 1_CD ES_NNP cells_NNS by_IN
        aggregating_VBG them_PRP with_IN tetraploid_NN embryos_NNS [_NN 7_CD 8_CD ]_NN ._. Although_IN
        we_PRP were_VBD able_JJ to_TO repeat_VB these_DT data_NNS using_VBG R_NN 1_CD ES_NNP cells_NNS we_PRP were_VBD
        unable_JJ to_TO generate_VB midgestation_NN embryos_NNS from_IN
        E_NNP 14_CD TG_NNP 2_CD a-derived_JJ strains_NNS of_IN 
        hprt_NN negative_JJ ES_NNP cell_NN lines_NNS using_VBG the_DT
        same_JJ approach_NN [_NN 9_CD 10_CD 11_CD ]_NN ._. We_PRP believed_VBD it_PRP was_VBD unlikely_JJ
        that_IN Hprt_NNP itself_PRP was_VBD required_VBN to_TO generate_VB ES_NNP cell-derived_JJ
        embryos_NNS because_IN 
        hprt_NN knockout_NN mice_NNS are_VBP viable_JJ and_CC
        fertile_JJ [_NN 12_CD ]_NN ._. E_NNP 14_CD TG_NNP 2_CD a-derived_JJ ES_NNP cell_NN lines_NNS contain_VBP a_DT
        large_JJ spontaneous_JJ deletion_NN encompassing_VBG 55_CD kb_NN of_IN the_DT 
        hprt_NN locus_JJ [_NN 13_CD ]_NN ._. Therefore_RB ,_, it_PRP
        seemed_VBD possible_JJ that_IN sequences_NNS within_IN this_DT region_NN were_VBD
        necessary_JJ to_TO maintain_VB ES_NNP cell_NN pluripotency_NN ._. However_RB ,_, we_PRP
        believed_VBD a_DT more_RBR likely_JJ scenario_NN was_VBD that_IN the_DT available_JJ
        lines_NNS contained_VBD unrelated_JJ genetic_JJ or_CC epigenetic_JJ alterations_NNS
        that_WDT were_VBD incompatible_JJ with_IN the_DT aggregation_NN procedure_NN ._.
        Consistent_NNP with_IN this_DT interpretation_NN ,_, Eggan_NNP 
        et_CC al_NN have_VBP recently_RB shown_VBN that_IN viable_JJ
        offspring_NN are_VBP more_RBR efficiently_RB produced_VBN through_IN
        tetraploid-mediated_JJ cloning_VBG from_IN outbred_JJ ES_NNP cell_NN line_NN
        compared_VBN to_TO inbred_JJ ES_NNP cell_NN lines_NNS [_NN 14_CD ]_NN ._. We_PRP ,_, therefore_RB ,_,
        believed_VBN it_PRP likely_JJ that_IN aggregation-compatible_JJ 
        hprt_NN negative_JJ ES_NNP cells_NNS could_MD be_VB
        generated_VBN by_IN targeted_VBN mutation_NN of_IN the_DT 
        hprt_NN gene_NN in_IN R_NN 1_CD ES_NNP cells_NNS ._. To_TO test_VB
        this_DT we_PRP generated_VBD a_DT targeting_VBG vector_NN to_TO replace_VB exon_NN 1_CD of_IN
        the_DT mouse_NN 
        hprt_NN gene_NN with_IN a_DT 
        neomycin_NN phosphotransferase_NN
        (_( neo_NN )_) gene_NN that_WDT conferred_VBD resistance_NN to_TO te_NN
        pharmacological_JJ inhibitor_NN G_NNP 418_CD in_IN ES_NNP cells_NNS (_( fig_NN 1_CD a_DT )_) ._.
        Following_VBG transfection_NN of_IN this_DT plasmid_NN into_IN R_NN 1_CD cells_NNS 192_CD
        clones_NNS that_WDT were_VBD resistant_JJ to_TO G_NNP 418_CD were_VBD collected_VBN and_CC grown_VBN
        in_IN the_DT presence_NN of_IN 6_CD -_: thioguanine_NN to_TO select_VB for_IN loss_NN of_IN Hprt_NNP
        activity_NN ._. Of_IN the_DT original_JJ 192_CD G_NNP 418_CD -_: resistant_JJ clones_NNS that_WDT
        were_VBD harvested_VBN only_RB one_CD ,_, named_VBN F_NN 3_CD ,_, was_VBD also_RB resistant_JJ to_TO
        6_CD -_: thioguanine_NN and_CC sensitive_JJ to_TO growth_VB in_IN HAT_NNP medium_NN (_( fig_NN
        3_CD b_SYM )_) ._. The_DT integrity_NN of_IN the_DT targeting_VBG event_NN was_VBD next_RB
        confirmed_VBN by_IN Southern_NNP blot_NN analysis_NN of_IN F_NN 3_CD genomic_JJ DNA_NNP ._. As_IN
        shown_VBN in_IN fig_NN 1_CD athe_NN correct_JJ integration_NN of_IN Neo_NNP at_IN the_DT 
        hprt_NN locus_JJ was_VBD predicted_VBN to_TO delete_VB a_DT
        BamH_NNP 1_CD restriction_NN endonuclease_NN cut-site_JJ from_IN intron_NN 1_CD and_CC
        replace_VB it_PRP with_IN a_DT BamH_NNP 1_CD site_NN that_WDT is_VBZ unique_JJ to_TO the_DT mutant_JJ 
        hprt_NN allele_NN ._. This_DT restriction_NN
        fragment_NN polymorphism_NN could_MD be_VB detected_VBN using_VBG an_DT 
        hprt-specific_JJ probe_NN (_( fig_NN 1_CD a_DT )_) ._. The_DT
        wild_JJ type_NN BamH_NNP 1_CD fragment_NN was_VBD predicted_VBN to_TO be_VB 7_CD ._. 0_CD kb_NN based_VBN
        on_IN sequence_NN analysis_NN while_IN the_DT mutant_JJ fragment_NN should_MD be_VB
        8_CD ._. 3_CD kb_NN ._. Fig_NNP 1_CD cshows_NNS that_WDT digestion_NN of_IN wild-type_JJ R_NN 1_CD ES_NNP cell_NN
        DNA_NNP with_IN BamH_NNP 1_CD did_VBD indeed_RB generate_VB a_DT 7_CD ._. 0_CD kb_NN fragment_NN that_WDT
        could_MD be_VB detected_VBN with_IN intron_NN 3_CD probe_NN ._. In_IN contrast_NN ,_, F_NN 3_CD
        cells_NNS were_VBD shown_VBN to_TO have_VB replaced_VBN this_DT fragment_NN with_IN an_DT 8_CD ._. 3_CD
        kb_NN BamH_NNP 1_CD fragment_NN thereby_RB confirming_VBG the_DT integrity_NN of_IN the_DT
        targeting_VBG event_NN ._.
        For_IN F_NN 3_CD cells_NNS to_TO be_VB a_DT suitable_JJ vehicle_NN for_IN the_DT generation_NN
        of_IN transgenic_JJ mice_NNS they_PRP should_MD be_VB competent_JJ to_TO generate_VB
        chimeric_JJ mice_NNS that_WDT can_MD transmit_VB alleles_NNS through_IN the_DT
        germline_NN ._. To_TO test_VB the_DT "_'' germline_NN potential_JJ "_'' of_IN F_NN 3_CD cells_NNS we_PRP
        first_RB generated_VBN chimeric_JJ mice_NNS by_IN aggregating_VBG F_NN 3_CD ES_NNP cells_NNS
        with_IN CD-_NNP 1_CD morulae_NN and_CC allowing_VBG them_PRP to_TO develop_VB to_TO term_VB 
        in_IN utero_NN ._. The_DT resulting_VBG chimeric_JJ
        males_NNS were_VBD bred_VBN with_IN CD-_NNP 1_CD females_NNS and_CC the_DT genotype_NN of_IN
        offspring_NN determined_VBN by_IN Southern_NNP blot_NN analysis_NN of_IN genomic_JJ
        DNA_NNP from_IN mouse_NN tails_NNS ._. Fig_NNP 1_CD cshows_NNS that_WDT agouti_NN F_NN 1_CD female_JJ
        mice_NNS contained_VBD both_DT the_DT mutant_JJ (_( paternal_NN )_) and_CC wild_JJ type_NN
        (_( maternal_NN )_) 
        hprt_NN alleles_NNS ._. In_IN contrast_NN ,_, the_DT agouti_NN
        F_NN 1_CD male_JJ mice_NNS contained_VBD only_RB a_DT wild-type_JJ 
        hprt_NN allele_NN inherited_VBN from_IN the_DT
        maternal_NN X-_NNP chromosome_NN as_IN expected_VBN ._. From_IN this_DT we_PRP were_VBD able_JJ
        to_TO conclude_VB that_DT F_NN 3_CD 
        hprt_NN null_NN ES_NNP cells_NNS are_VBP indeed_RB
        competent_JJ to_TO transmit_VB alleles_NNS through_IN the_DT germline_NN and_CC that_IN
        the_DT resulting_VBG offspring_NN were_VBD fertile_JJ and_CC viable_JJ as_IN reported_VBN
        previously_RB [_NN 12_CD ]_NN ._.
        We_PRP next_RB addressed_VBN whether_IN embryos_NNS could_MD be_VB generated_VBN
        solely_RB from_IN F_NN 3_CD Hprt_NNP negative_JJ ES_NNP cells_NNS by_IN aggregating_VBG these_DT
        cells_NNS with_IN tetraploid_NN CD-_NNP 1_CD embryos_NNS and_CC allowing_VBG them_PRP to_TO
        develop_VB 
        in_IN utero_NN until_IN day_NN 13_CD of_IN gestation_NN
        (_( El_NNP 3_LS )_) ._. Figs_NNP 2_CD a_DT ,_, b_SYM ,_, cshow_NN that_DT F_NN 3_CD cells_NNS could_MD indeed_RB give_VB
        rise_NN to_TO normal_JJ embryos_NNS (_( n_NN =_SYM 10_CD )_) ._. All_DT embryos_NNS exhibited_VBN
        characteristic_JJ features_NNS of_IN midgestation_NN stages_NNS of_IN
        development_NN including_VBG normal_JJ rostral-caudal_JJ patterning_VBG ,_,
        beating_NN hearts_NNS ,_, normal_JJ limb_NN formation_NN including_VBG the_DT
        formation_NN of_IN fingers_NNS ._. F_NN 3_CD cells_NNS derive_VB from_IN the_DT agouti_NN
        (_( pigmented_JJ )_) SV_NNP 129_CD /_NN J_NNP strain_NN of_IN mice_NNS ._. In_IN contrast_NN ,_, albino_NN
        CD-_NNP 1_CD mice_NNS donated_VBD the_DT tetraploid_NN morulae_NN used_VBN in_IN the_DT
        aggregation_NN procedure_NN ._. The_DT finding_NN ,_, shown_VBN in_IN figs_NNS 2_CD a_DT ,_, b_SYM ,_, c_SYM ,_,
        that_IN all_PDT the_DT resulting_VBG embryos_NNS displayed_VBD clear_JJ retinal_JJ
        pigmentation_NN strongly_RB implied_VBD that_IN the_DT embryos_NNS were_VBD F_NN 3_CD ES_NNP
        cell-derived_JJ ._. We_PRP confirmed_VBD this_DT by_IN determining_VBG the_DT genotype_NN
        of_IN the_DT embryos_NNS by_IN Southern_NNP blot_NN analyses_NNS of_IN genomic_JJ DNA_NNP ._.
        Fig_NNP 2_CD dshows_NNS that_IN all_DT embryos_NNS contained_VBD a_DT restriction_NN
        fragment_NN polymorphism_NN that_WDT was_VBD indicative_JJ of_IN deletion_NN of_IN 
        hprt_NN exon_NN 1_CD ._. No_DT wild_JJ type_NN 
        hprt_NN allele_NN was_VBD detected_VBN confirming_VBG
        that_IN the_DT embryos_NNS were_VBD generated_VBN entirely_RB from_IN F_NN 3_CD cells_NNS ._.
        These_DT data_NNS demonstrate_VBP that_IN the_DT 
        hprt_NN gene_NN is_VBZ not_RB essential_JJ for_IN the_DT
        generation_NN of_IN embryos_NNS from_IN ES_NNP cells_NNS by_IN tetraploid_NN
        aggregation_NN and_CC that_DT F_NN 3_CD cells_NNS should_MD could_MD provide_VB a_DT
        suitable_JJ vehicle_NN for_IN the_DT direct_JJ generation_NN of_IN transgenic_JJ
        mouse_NN embryos_NNS ._.
        Previously_RB it_PRP has_VBZ been_VBN shown_VBN that_IN a_DT targeting_VBG vector_NN ,_,
        pMP_NN 8_CD ,_, can_MD correct_VB the_DT loss_NN of_IN Hprt_NNP activity_NN in_IN E_NNP 14_CD TG_NNP 2_CD a_DT ES_NNP
        cells_NNS that_WDT lack_NN exons_NNS 1_CD and_CC 2_CD of_IN the_DT 
        hprt_NN gene_NN [_NN 2_CD 15_CD ]_NN ._. The_DT design_NN of_IN
        this_DT vector_NN implied_VBN that_IN it_PRP should_MD also_RB be_VB capable_JJ of_IN
        correcting_VBG the_DT 
        hprt_NN exon_NN 1_CD deficiency_NN in_IN F_NN 3_CD cells_NNS
        and_CC could_MD ,_, therefore_RB ,_, be_VB used_VBN to_TO introduce_VB transgenes_NNS into_IN
        the_DT 
        hprt_NN locus_JJ by_IN homologous_RB
        recombination_NN ._. To_TO test_VB this_DT we_PRP generated_VBD a_DT modified_VBN vector_NN
        based_VBN on_IN pMP_NN 8_CD ._. The_DT practical_JJ features_NNS of_IN this_DT modification_NN
        are_VBP that_IN it_PRP removes_VBZ the_DT lacZ_NN sequences_NNS in_IN the_DT vector_NN
        backbone_NN and_CC reduces_VBZ the_DT overall_JJ size_NN of_IN the_DT vector_NN ,_, both_DT
        of_IN which_WDT improve_VBP subsequent_JJ cloning_VBG steps_NNS ._. This_DT vector_NN ,_,
        pMP_NN 8_CD NEBΔLacZ_NNP ,_, contains_VBZ a_DT 5_CD '_POS arm_NN of_IN homology_NN consisting_VBG of_IN
        3_CD ._. 4_CD kb_NN of_IN mouse_NN 5_CD '_POS 
        hprt_NN genomic_JJ DNA_NNP flanking_VBG a_DT unique_JJ
        Not_RB 1_CD restriction_NN endonuclease_NN cut_NN site_NN ._. The_DT 3_CD '_POS arm_NN of_IN
        homology_NN contains_VBZ 1_CD ._. 8_CD kb_NN of_IN the_DT human_JJ 
        hprt_NN gene_NN that_WDT includes_VBZ exon_NN 1_CD and_CC 2_CD ._. 9_CD
        kb_NN of_IN mouse_NN genomic_JJ sequence_NN that_WDT includes_VBZ exon_NN 2_CD (_( fig_NN 3_CD a_DT )_)
        as_IN described_VBN previously_RB [_NN 15_CD ]_NN ._. Homologous_NNP recombination_NN
        at_IN the_DT modified_VBN 
        hprt_NN locus_JJ in_IN F_NN 3_CD cells_NNS should_MD
        substitute_VB genomic_JJ DNA_NNP containing_VBG 
        hprt_NN exons_NNS 1_CD and_CC 2_CD for_IN 
        neo_NN thereby_RB reconstituting_VBG a_DT gene_NN
        encoding_VBG active_JJ Hprt_NNP (_( fig_NN 3_CD a_DT )_) ._. Moreover_RB ,_, only_RB cells_NNS having_VBG
        undergone_VBN a_DT successful_JJ homologous_RB recombination_NN event_NN
        should_MD become_VB HAT_NNP resistant_JJ and_CC carry_VB the_DT targeted_VBN
        transgene_NN ._. To_TO assess_VB the_DT efficiency_NN of_IN this_DT approach_NN we_PRP
        attempted_VBD to_TO target_VB a_DT LacZ_NNP reporter_NN transgene_NN whose_WP$
        expression_NN is_VBZ controlled_VBN by_IN the_DT promoter_NN from_IN the_DT alpha_NN
        myosin_NN heavy_JJ chain_NN (_( αMHC_NN )_) gene_NN to_TO the_DT modified_VBN 
        hprt_NN locus_JJ in_IN F_NN 3_CD cells_NNS ._. We_PRP chose_VBD the_DT
        αMHC_NN promoter_NN because_IN others_NNS have_VBP demonstrated_VBN ,_, using_VBG
        traditional_JJ transgenic_JJ procedures_NNS ,_, that_IN it_PRP directs_VBZ high_JJ
        levels_NNS of_IN reporter_NN gene_NN expression_NN specifically_RB in_IN cardiac_JJ
        tissue_NN of_IN early_JJ mouse_NN embryos_NNS [_NN 16_CD 17_CD 18_CD ]_NN ._. Cells_NNP were_VBD
        selected_VBN for_IN resistance_NN to_TO HAT_NNP following_VBG electroporation_NN of_IN
        the_DT α_NN 
        MHC-LacZ_NNP transgene-containing_JJ
        plasmid_NN ._. 16_CD HAT_NNP resistant_JJ cells_NNS lines_NNS were_VBD collected_VBN and_CC
        their_PRP$ genotype_NN determined_VBN by_IN Southern_NNP blot_NN analysis_NN ._. Fig_NNP
        3_CD cshows_NNS that_IN ,_, in_IN contrast_NN to_TO F_NN 3_CD cells_NNS ,_, a_DT probe_NN that_WDT
        specifically_RB recognizes_VBZ the_DT LacZ_NNP transgene_NN identified_VBD a_DT 6_CD ._. 7_CD
        kb_NN EcoRV_NNP fragment_NN in_IN HAT-resistant_NNP ES_NNP cell_NN lines_NNS ._. Of_IN the_DT 16_CD
        HAT-resistant_NNP colonies_NNS retrieved_VBD 15_CD contained_VBD LacZ_NNP ._.
        Furthermore_RB ,_, fig_NN 3_CD bshows_NNS that_IN these_DT cells_NNS had_VBD become_VBN G_NNP 418_CD
        and_CC 6_CD -_: thioguanine_NN sensitive_JJ confirming_VBG that_IN the_DT 
        neo_NN gene_NN had_VBD indeed_RB been_VBN replaced_VBN
        with_IN 
        hprt_NN -_: coding_VBG sequences_NNS in_IN the_DT F_NN 3_CD
        cells_NNS ._. These_DT data_NNS confirm_VBP that_IN this_DT selection_NN strategy_NN is_VBZ
        extremely_RB efficient_JJ in_IN identifying_VBG ES_NNP cell_NN clones_NNS
        containing_VBG correctly_RB targeted_VBN transgenes_NNS [_NN 2_CD ]_NN ._.
        The_DT ultimate_JJ use_NN of_IN this_DT procedure_NN is_VBZ to_TO generate_VB clonal_NN
        transgenic_JJ mouse_NN embryos_NNS directly_RB from_IN the_DT modified_VBN ES_NNP
        cells_NNS ._. Success_NNP in_IN this_DT would_MD provide_VB a_DT system_NN in_IN which_WDT to_TO
        express_VB alleles_NNS with_IN potentially_RB lethal_JJ phenotypes_NNS in_IN the_DT
        developing_VBG embryo_NN ._. We_PRP ,_, therefore_RB ,_, determined_VBN whether_IN
        embryos_NNS could_MD be_VB generated_VBN from_IN the_DT F_NN 3_CD cells_NNS that_WDT contained_VBD
        an_DT αMHC-LacZ_JJ transgene_NN and_CC whether_IN these_DT embryos_NNS
        appropriately_RB expressed_VBD β-galactosidase_JJ ._. E_NNP 8_CD ._. 5_LS embryos_NNS were_VBD
        generated_VBN from_IN three_CD independent_JJ αMHC-LacZ_JJ cell_NN lines_NNS and_CC
        stained_JJ for_IN expression_NN of_IN β-galactosidase_JJ ._. Representative_NNP
        embryos_NNS ,_, shown_VBN in_IN fig_NN 3_CD dall_NN developed_VBN normally_RB and_CC
        expressed_VBD high_JJ levels_NNS of_IN β-galactosidase_JJ in_IN the_DT developing_VBG
        heart_NN ,_, mimicking_VBG the_DT expression_NN of_IN endogenous_JJ αMHC_NN [_NN 16_CD ]_NN ._.
        Importantly_NNP ,_, none_NN of_IN the_DT embryos_NNS exhibited_VBN ectopic_JJ patterns_NNS
        of_IN expression_NN lending_NN further_JJ support_NN to_TO the_DT proposal_NN that_DT
        expression_NN of_IN transgenes_NNS introduced_VBN to_TO the_DT 
        hprt_NN locus_JJ is_VBZ primarily_RB dependent_JJ on_IN
        the_DT accompanying_VBG transcriptional_NN regulatory_JJ elements_NNS [_NN 2_CD ]_NN
        ._.
      
      
        Discussion_NNP and_CC conclusions_NNS
        Here_RB we_PRP have_VBP described_VBN the_DT generation_NN of_IN an_DT ES_NNP cell_NN line_NN
        and_CC a_DT procedure_NN that_WDT will_MD allow_VB the_DT phenotypic_JJ analyses_NNS of_IN
        transgenic_JJ embryos_NNS expressing_VBG lethal_JJ alleles_NNS ._. This_DT
        procedure_NN is_VBZ an_DT important_JJ addition_NN to_TO the_DT available_JJ
        repertoire_NN of_IN molecular_JJ genetic_JJ techniques_NNS available_JJ to_TO
        developmental_NN biologists_NNS because_IN it_PRP overcomes_VBZ several_JJ
        deficiencies_NNS associated_VBN with_IN alternative_NN transient_JJ
        transgenic_JJ approaches_NNS normally_RB used_VBN to_TO study_VB
        gain-of-function_JJ and_CC dominant-negative_JJ alleles_NNS ._. Traditional_JJ
        procedures_NNS rely_VBP on_IN the_DT generation_NN of_IN transgenic_JJ embryos_NNS
        through_IN micro_JJ injection_NN of_IN fertilized_VBN mouse_NN eggs_NNS ._. Using_VBG
        this_DT approach_NN an_DT unpredictable_JJ number_NN of_IN transgene-copies_JJ
        are_VBP incorporated_VBN at_IN a_DT random_JJ location_NN in_IN the_DT recipient_JJ
        genome_NN ._. This_DT can_MD result_VB in_IN ectopic_JJ expression_NN of_IN the_DT
        transgene_NN because_IN both_DT copy_NN number_NN and_CC the_DT site_NN integration_NN
        can_MD influence_VB transgene_NN expression_NN ._.
        In_IN the_DT approach_NN described_VBD here_RB ,_, a_DT targeting_VBG vector_NN that_WDT
        contains_VBZ exon_NN 1_CD of_IN the_DT 
        hprt_NN gene_NN along_IN with_IN a_DT specific_JJ
        transgene_NN is_VBZ used_VBN to_TO reconstitute_NN Hprt_NNP activity_NN in_IN Hprt_NNP
        negative_JJ ES_NNP cells_NNS ._. Successful_JJ targeting_VBG of_IN the_DT transgene_NN to_TO
        the_DT 
        hprt_NN locus_JJ in_IN Hprt_NNP negative_JJ ES_NNP cells_NNS
        can_MD be_VB selected_VBN by_IN growing_VBG transfected_JJ cells_NNS in_IN HAT_NNP medium_NN ._.
        The_DT efficiency_NN of_IN this_DT selection_NN procedure_NN is_VBZ such_JJ that_WDT
        close_JJ to_TO all_DT HAT_NNP resistant_JJ colonies_NNS contain_VBP a_DT correctly_RB
        targeted_VBN transgene_NN ._. Moreover_RB ,_, because_IN the_DT transgene_NN is_VBZ
        introduced_VBN into_IN the_DT 
        hprt_NN locus_JJ its_PRP$ expression_NN is_VBZ
        dependent_JJ upon_IN the_DT inclusion_NN of_IN specific_JJ transcriptional_NN
        regulatory_JJ elements_NNS and_CC remains_VBZ relatively_RB unaffected_JJ by_IN
        the_DT local_JJ chromatin_NN environment_NN [_NN 2_CD ]_NN ._. A_DT major_JJ advantage_NN
        of_IN this_DT targeted_JJ transgenic_JJ approach_NN compared_VBN to_TO
        traditional_JJ transgenics_NNS is_VBZ that_DT transgene_NN expression_NN is_VBZ
        predictable_JJ so_RB expression_NN at_IN ectopic_JJ sites_NNS is_VBZ largely_RB
        avoided_VBN ._. The_DT availability_NN of_IN F_NN 3_CD Hprt_NNP negative_JJ ES_NNP cells_NNS
        allows_VBZ transgenic_JJ embryos_NNS to_TO be_VB derived_VBN directly_RB from_IN
        transgenic_JJ ES_NNP cells_NNS by_IN aggregating_VBG the_DT cells_NNS with_IN
        tetraploid_NN embryos_NNS and_CC allowing_VBG them_PRP to_TO develop_VB 
        in_IN utero_NN ._. Each_DT embryo_NN is_VBZ ,_, in_IN effect_NN ,_,
        clonal_NN because_IN it_PRP is_VBZ generated_VBN from_IN a_DT single_JJ clonal_NN ES_NNP cell_NN
        line_NN ._. This_DT allows_VBZ reproducible_JJ comparison_NN of_IN the_DT phenotype_NN
        generated_VBN by_IN a_DT given_VBN transgene_NN at_IN different_JJ developmental_NN
        stages_NNS ._. Moreover_RB ,_, because_IN the_DT transgene_NN is_VBZ present_JJ as_IN a_DT
        single_JJ copy_NN at_IN a_DT known_VBN site_NN of_IN integration_NN it_PRP circumvents_VBZ
        the_DT need_NN to_TO generate_VB many_JJ different_JJ transgenic_JJ lines_NNS from_IN a_DT
        given_VBN construct_VB as_IN is_VBZ the_DT case_NN when_WRB using_VBG a_DT transient_JJ
        transgenic_JJ procedure_NN ._.
        There_EX are_VBP many_JJ potential_JJ uses_NNS for_IN this_DT method_NN of_IN
        generating_NN transgenic_JJ mouse_NN embryos_NNS ._. The_DT most_RBS obvious_JJ is_VBZ
        that_IN it_PRP provides_VBZ a_DT mechanism_NN for_IN generating_NN embryos_NNS that_WDT
        express_VBP alleles_NNS that_WDT are_VBP predicted_VBN ,_, or_CC known_VBN ,_, to_TO be_VB
        detrimental_JJ to_TO normal_JJ embryonic_JJ development_NN ,_, for_IN example_NN
        dominant-negative_JJ or_CC gain-of-function_JJ alleles_NNS ._. Indeed_RB ,_, the_DT
        expression_NN of_IN dominant_JJ negative_JJ alleles_NNS that_WDT can_MD
        potentially_RB disrupt_VB multiple_JJ members_NNS of_IN a_DT gene_NN family_NN has_VBZ
        been_VBN used_VBN extensively_RB in_IN Xenopus_NNP laevis_NNS and_CC has_VBZ ,_, for_IN
        example_NN ,_, helped_VBD elucidate_NN the_DT action_NN of_IN fibroblast_NN growth_NN
        factors_NNS during_IN mesoderm_NN formation_NN [_NN 19_CD ]_NN ._. Such_JJ alleles_NNS are_VBP
        particularly_RB useful_JJ when_WRB a_DT null_NN allele_NN in_IN the_DT same_JJ gene_NN
        causes_VBZ a_DT disruptive_JJ phenotype_NN prior_RB to_TO the_DT stage_NN of_IN
        development_NN of_IN interest_NN ._. Choosing_NNP a_DT promoter_NN that_WDT expresses_VBZ
        the_DT dominant_JJ negative_JJ allele_NN later_RB in_IN development_NN or_CC in_IN a_DT
        specific_JJ cell_NN type_NN could_MD potentially_RB circumvent_VB any_DT early_JJ
        phenotype_NN associated_VBN with_IN a_DT null_NN allele_NN ._.
        Another_DT important_JJ use_NN of_IN this_DT procedure_NN could_MD be_VB to_TO
        identify_VB transcriptional_NN regulatory_JJ regions_NNS that_WDT control_NN
        expression_NN of_IN specific_JJ genes_NNS during_IN development_NN ._. Transgenic_NNP
        mice_NNS have_VBP been_VBN extensively_RB used_VBN to_TO identify_VB regulatory_JJ
        elements_NNS that_WDT control_NN gene_NN expression_NN 
        in_IN vivo_NN [_NN 20_CD 21_CD ]_NN ._. This_DT has_VBZ ,_, in_IN turn_NN
        allowed_VBN the_DT elucidation_NN of_IN regulatory_JJ networks_NNS that_WDT control_NN
        cell_NN differentiation_NN during_IN development_NN ._. In_IN this_DT regard_NN ,_,
        the_DT use_NN of_IN F_NN 3_CD cells_NNS coupled_VBN with_IN targeting_VBG transgenes_NNS to_TO
        the_DT 
        hprt_NN locus_JJ offers_VBZ two_CD major_JJ
        advantages_NNS over_IN traditional_JJ transgenic_JJ approaches_NNS ._. The_DT
        first_JJ is_VBZ that_IN it_PRP is_VBZ extremely_RB rapid_JJ ._. Once_RB the_DT targeting_VBG
        construct_VB is_VBZ in_IN hand_NN it_PRP takes_VBZ approximately_RB four_CD to_TO five_CD
        weeks_NNS to_TO generate_VB transgenic_JJ mouse_NN embryos_NNS ._. The_DT second_JJ
        advantage_NN is_VBZ due_JJ to_TO the_DT presence_NN of_IN the_DT transgene_NN at_IN a_DT
        known_VBN and_CC constant_JJ integration_NN site_NN ._. This_DT potentially_RB
        allows_VBZ the_DT comparison_NN of_IN levels_NNS of_IN reporter_NN gene_NN expression_NN
        driven_VBN by_IN different_JJ promoters_NNS thereby_RB offering_VBG a_DT
        quantitative_JJ 
        in_IN vivo_NN transgenic_JJ assay_NN ._.
        In_IN sum_NN ,_, the_DT availability_NN of_IN tetraploid_NN
        aggregation-competent_JJ ES_NNP cells_NNS that_WDT support_NN targeting_VBG of_IN
        transgenes_NNS to_TO the_DT 
        hprt_NN locus_JJ should_MD facilitate_VB the_DT
        rapid_JJ analysis_NN of_IN transcriptional_NN regulatory_JJ elements_NNS 
        in_IN vivo_NN as_RB well_RB as_IN the_DT phenotypic_JJ
        characterization_NN of_IN alleles_NNS that_WDT are_VBP incompatible_JJ with_IN
        normal_JJ development_NN ._. We_PRP ,_, therefore_RB ,_, believe_VBP that_DT F_NN 3_CD cells_NNS
        provide_VBP a_DT powerful_JJ new_JJ tool_NN for_IN molecular_JJ geneticists_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Plasmids_NNP
          
            pΔHprt_NN
            The_DT targeting_VBG plasmid_NN used_VBN to_TO delete_VB 
            hprt_NN exon_NN 1_CD was_VBD called_VBN pΔHprt_NN to_TO
            indicate_VB this_DT deletion_NN ._. It_PRP was_VBD derived_VBN from_IN the_DT plasmid_NN
            pOS_NN ._. DUP_NNP /_NN DEL_NNP that_WDT contained_VBD the_DT 
            neomycin_NN phosphotransferase_NN
            (_( neo_NN )_) gene_NN that_WDT confers_VBZ resistance_NN to_TO the_DT
            pharmacological_JJ inhibitor_NN G_NNP 418_CD and_CC also_RB contains_VBZ the_DT
            Herpes_NNP Simplex_NNP Virus_NNP 
            thymidine_NN kinase_NN (_( HSV-TK_NNP )_) that_WDT
            confers_VBZ sensitivity_NN to_TO gancyclovir_NN ._. Importantly_NNP the_DT 
            neo_NN gene_NN is_VBZ flanked_JJ by_IN 
            loxP_NN sequences_NNS permitting_VBG loss_NN of_IN
            G_NNP 418_CD resistance_NN where_WRB useful_JJ ._. pΔHprt_NN was_VBD constructed_VBN by_IN
            introducing_VBG a_DT 2_CD ._. 5_CD Kb_NNP BamHI_NNP /_NN HindIII_NNP fragment_NN of_IN 5_CD '_POS 
            hprt_NN genomic_JJ DNA_NNP (_( E_NNP 14_CD TG_NNP 2_CD a_DT origin_NN )_)
            from_IN the_DT plasmid_NN pMP_NN 8_CD into_IN the_DT Hpa_NNP 1_CD site_NN of_IN pOS_NN ._. DUP_NNP /_NN DEL_NNP
            [_NN 15_CD ]_NN ._. The_DT ends_NNS of_IN the_DT fragments_NNS were_VBD made_VBN blunt_VB
            using_VBG Klenow_NNP ._. The_DT 3_CD '_POS arm_NN of_IN homology_NN was_VBD introduced_VBN
            into_IN the_DT unique_JJ Bcl_NNP 1_CD site_NN of_IN the_DT previous_JJ plasmid_NN as_IN a_DT
            7_CD Kb_NNP BamHI_NNP fragment_NN from_IN pMP_NN 1_CD (_( SV_NNP 129_CD origin_NN )_) that_WDT
            contained_JJ murine_NN 
            hprt_NN exons_NNS 2_CD and_CC 3_CD ._.
          
          
            pMP_NN 8_CD NEBΔLacZ_NNP
            The_DT plasmid_NN pMP_NN 8_CD NEBΔLacZ_NNP was_VBD generated_VBN by_IN ligating_VBG
            an_DT 8_CD kb_NN Xba_NNP 1_CD fragment_NN from_IN pMP_NN 8_CD into_IN the_DT Xba_NNP 1_CD site_NN of_IN
            pNEB_NN 193_CD (_( New_NNP England_NNP Biolabs_NNP )_) from_IN which_WDT LacZ_NNP sequences_NNS
            had_VBD been_VBN removed_VBN as_IN a_DT NarI_NNP /_NN EcoRI_NNP fragment_NN [_NN 15_CD ]_NN ._. This_DT
            
            hprt_NN replacement_NN vector_NN contains_VBZ
            a_DT 5_CD '_POS arm_NN of_IN 
            hprt_NN homology_NN consisting_VBG of_IN 3_CD ._. 4_CD
            kb_NN of_IN mouse_NN 5_CD '_POS 
            hprt_NN genomic_JJ DNA_NNP flanking_VBG a_DT
            unique_JJ Not_RB 1_CD cloning_VBG site_NN ._. The_DT 3_CD '_POS arm_NN of_IN homology_NN
            contains_VBZ 1_CD ._. 8_CD kb_NN of_IN the_DT human_JJ 
            hprt_NN gene_NN that_WDT includes_VBZ exon_NN 1_CD and_CC
            2_CD ._. 9_CD kb_NN of_IN mouse_NN genomic_JJ sequence_NN that_WDT includes_VBZ exon_NN 2_CD ._.
            A_DT detailed_VBN description_NN of_IN the_DT pMP_NN 8_CD targeting_VBG vector_NN ,_,
            from_IN which_WDT these_DT sequences_NNS were_VBD derived_VBN ,_, has_VBZ been_VBN
            described_VBN previously_RB [_NN 15_CD ]_NN ._. A_DT partial_JJ nucleotide_NN
            sequence_NN of_IN pMP_NN 8_CD NEBΔLacZ_NNP is_VBZ available_JJ from_IN S_NNP ._. A_DT ._. D_NNP ._. upon_IN
            request_NN ._.
          
          
            pαMHC-LacZ-Hprt_JJ
            This_DT targeting_VBG vector_NN was_VBD constructed_VBN by_IN inserting_VBG a_DT
            9_CD ._. 7_CD kb_NN αMHCLacZ_NN expression_NN cassette_NN into_IN the_DT NotI_NNP site_NN
            of_IN pMP_NN 8_CD NEBΔLacZ_NNP ._. The_DT 9_CD ._. 7_CD kb_NN αMHCLacZ_NN expression_NN
            cassette_NN was_VBD constructed_VBN by_IN inserting_VBG a_DT 3_CD ._. 6_CD kb_NN
            SalI_NNP /_NN HindIII_NNP fragment_NN from_IN pLacF_NN containing_VBG a_DT 
            lacZ_NN gene_NN that_WDT incorporates_VBZ a_DT
            nuclear_JJ localization_NN signal_NN into_IN the_DT SalI_NNP /_NN HindIII_NNP site_NN
            of_IN an_DT αMHC_NN expression_NN module_NN ._.
          
        
        
          ES_NNP cell_NN culture_NN ,_, gene_NN targeting_VBG and_CC
          selection_NN
          All_DT ES_NNP cell_NN lines_NNS were_VBD cultured_JJ on_IN mitotically_RB
          inactivated_JJ primary_JJ embryonic_JJ fibroblasts_NNS in_IN ES_NNP cell_NN
          medium_NN supplemented_JJ with_IN recombinant_JJ leukemia_NN inhibitory_NN
          factor_NN (_( LIF_NNP )_) as_IN described_VBN elsewhere_RB [_NN 22_CD ]_NN ._. F_NN 3_CD cells_NNS
          were_VBD generated_VBN by_IN introducing_VBG 100_CD μg_NN of_IN Not_RB 1_CD digested_VBN
          pΔHPRT_NN plasmid_NN into_IN 1_CD ._. 5_CD ×_NN 10_CD 8_CD R_NN 1_CD ES_NNP cells_NNS by_IN
          electroporation_NN at_IN 250_CD volts_NNS /_NN 500_CD μf_NN /_NN resistance_NN 8_CD using_VBG a_DT
          BTX_NNP ECM_NNP 600_CD electroporation_NN system_NN [_NN 7_CD ]_NN ._. Cells_NNP
          containing_VBG 
          neo_NN were_VBD selected_VBN by_IN supplementing_VBG
          the_DT ES_NNP cell_NN medium_NN with_IN 250_CD μg_NN /_NN ml_NN Geneticin_NNP (_( G_NNP 418_CD ,_,
          Gibco-_NNP BRL_NNP )_) and_CC negative_JJ selection_NN against_IN 
          Hsv-tk_NNP gene_NN expression_NN was_VBD achieved_VBN
          by_IN including_VBG 2_CD μM_NN gancyclovir_NN (_( Roche_NNP )_) ._. To_TO identify_VB cells_NNS
          that_WDT had_VBD lost_VBN HPRT_NNP activity_NN G_NNP 418_CD /_NN gancyclovir-resistant_JJ
          colonies_NNS were_VBD collected_VBN and_CC expanded_VBN in_IN 96_CD well_RB plates_NNS in_IN
          the_DT presence_NN of_IN 250_CD μg_NN /_NN ml_NN 6_CD -_: thiogaunine_NN ._. Introduction_NNP of_IN
          transgenes_NNS into_IN the_DT 
          hprt_NN locus_JJ of_IN F_NN 3_CD cells_NNS was_VBD achieved_VBN
          using_VBG the_DT following_NN procedure_NN ._. F_NN 3_CD cells_NNS were_VBD grown_VBN for_IN
          two_CD passages_NNS in_IN media_NNS containing_VBG 250_CD μg_NN /_NN ml_NN 6_CD -_: thioguanine_NN ._.
          100_CD μg_NN of_IN linear_JJ targeting_VBG vector_NN plasmid_NN was_VBD introduced_VBN
          into_IN 1_CD ._. 5_CD ×_NN 10_CD 8_CD F_NN 3_CD ES_NNP cells_NNS by_IN electroporation_NN ._. Cells_NNP were_VBD
          grown_VBN for_IN 2_CD days_NNS before_IN adding_VBG HAT_NNP (_( Sigma_NNP )_) to_TO the_DT growth_NN
          medium_NN ._. HAT_NNP resistant_JJ colonies_NNS were_VBD harvested_VBN after_IN 10_CD
          days_NNS growth_NN in_IN HAT-containing_NNP medium_NN ._.
        
        
          Tetraploid_NNP and_CC diploid_NN embryo_NN aggregation_NN
          ES-cell_NNP derived_VBD embryos_NNS were_VBD generated_VBN by_IN aggregating_VBG
          clumps_NNS of_IN around_IN twenty_CD ES_NNP cells_NNS with_IN individual_JJ eight_CD
          cell_NN embryos_NNS or_CC four_CD cell_NN embryos_NNS that_WDT had_VBD been_VBN made_VBN
          tetraploid_NN by_IN electrofusion_NN as_IN described_VBN previously_RB [_NN 7_CD 9_CD
          23_CD ]_NN ._. ES_NNP cell_NN :_: embryo_NN aggregates_NNS were_VBD cultured_JJ overnight_JJ
          and_CC those_DT that_WDT formed_VBD blastocysts_NNS were_VBD transferred_VBN to_TO the_DT
          uteri_NN of_IN psuedo-pregnant_JJ females_NNS surrogate_JJ mothers_NNS ._. To_TO
          generate_VB chimeric_JJ mice_NNS the_DT embryos_NNS were_VBD allowed_VBN to_TO
          develop_VB to_TO term_VB ._. ES_NNP cell-derived_JJ embryos_NNS were_VBD harvested_VBN
          at_IN pre-determined_JJ developmental_NN stages_NNS and_CC DNA_NNP prepared_VBD
          for_IN Southern_NNP blot_NN analysis_NN or_CC fixed_VBN and_CC processed_VBN to_TO
          identify_VB β-galactosidase_JJ expression_NN using_VBG standard_JJ
          protocols_NNS ._.
        
      
    
  
